StreetInsider.com News Articles

Kalaris to present TH103 phase 1 data at Macula Society meeting

Wed, 28 Jan 2026 16:05:08 -0500

Kalaris Therapeutics Inc. (NASDAQ: KLRS) announced it will present clinical data from its Phase 1 study of TH103 at the 49th Annual Meeting of the Macula Society, scheduled for February 25-28 in San Diego, California.

The presentation will include safety, tolerability, pharmacokinetics and early efficacy outcomes following intravitreal administration of TH103 in patients with treatment-naive neovascular age-related macular degeneration. TH103 is an investigational therapy designed to achieve enhanced VEGF inhibition and increased intraocular retention.

Dr. Dean Eliott, S.E. Gragoudas Professor of Ophthalmology at Harvard Medical School and Director Emeritus of Retina Service at Massachusetts Eye & Ear Infirmary, will present the data

Kalaris to present TH103 phase 1 data at Macula Society meeting

Wed, 28 Jan 2026 16:05:08 -0500

Dr. Dean Eliott, S.E. Gragoudas Professor of Ophthalmology at Harvard Medical School and Director Emeritus of Retina Service at Massachusetts Eye & Ear Infirmary, will present the data

Kalaris to present TH103 phase 1 data at Macula Society meeting

Wed, 28 Jan 2026 16:05:08 -0500

Dr. Dean Eliott, S.E. Gragoudas Professor of Ophthalmology at Harvard Medical School and Director Emeritus of Retina Service at Massachusetts Eye & Ear Infirmary, will present the data

Kalaris to present TH103 phase 1 data at Macula Society meeting

Wed, 28 Jan 2026 16:05:08 -0500

Dr. Dean Eliott, S.E. Gragoudas Professor of Ophthalmology at Harvard Medical School and Director Emeritus of Retina Service at Massachusetts Eye & Ear Infirmary, will present the data

Kalaris to present TH103 phase 1 data at Macula Society meeting

Wed, 28 Jan 2026 16:05:08 -0500

Dr. Dean Eliott, S.E. Gragoudas Professor of Ophthalmology at Harvard Medical School and Director Emeritus of Retina Service at Massachusetts Eye & Ear Infirmary, will present the data

Kalaris to present TH103 phase 1 data at Macula Society meeting

Wed, 28 Jan 2026 16:05:08 -0500

Dr. Dean Eliott, S.E. Gragoudas Professor of Ophthalmology at Harvard Medical School and Director Emeritus of Retina Service at Massachusetts Eye & Ear Infirmary, will present the data

Kalaris to present TH103 phase 1 data at Macula Society meeting

Wed, 28 Jan 2026 16:05:08 -0500

Dr. Dean Eliott, S.E. Gragoudas Professor of Ophthalmology at Harvard Medical School and Director Emeritus of Retina Service at Massachusetts Eye & Ear Infirmary, will present the data

Kalaris to present TH103 phase 1 data at Macula Society meeting

Wed, 28 Jan 2026 16:05:08 -0500

Dr. Dean Eliott, S.E. Gragoudas Professor of Ophthalmology at Harvard Medical School and Director Emeritus of Retina Service at Massachusetts Eye & Ear Infirmary, will present the data

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting